“Immune-Related Adverse Events After Combination Checkpoint Blockade: A Short Communication on Steroid-Sparing Practice”, TMTJ, vol. 3, no. 2, pp. 110–119, Dec. 2024, doi: 10.5281/zenodo.22649312.